Hi-Tech Pharmacal (HITK) Receives Final Approval For Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)
1/23/2014 9:37:48 AM
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day), the generic for ISTA Pharmaceuticals’ Bromday ® ophthalmic solution, 0.09%. The product is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. Hi-Tech plans to launch the product immediately.
Help employers find you! Check out all the jobs and post your resume.
comments powered by